Filter Results:
(1,272)
Show Results For
- All HBS Web
(1,272)
- People (4)
- News (228)
- Research (897)
- Events (4)
- Multimedia (7)
- Faculty Publications (489)
Show Results For
- All HBS Web
(1,272)
- People (4)
- News (228)
- Research (897)
- Events (4)
- Multimedia (7)
- Faculty Publications (489)
- January 2014 (Revised January 2014)
- Supplement
GlaxoSmithKline in China (C)
By: John Quelch and Margaret L. Rodriguez
Keywords: China; Healthcare; Pharmaceutical Sales; Ethics; Multinational Firms and Management; Pharmaceutical Industry; China
Quelch, John, and Margaret L. Rodriguez. "GlaxoSmithKline in China (C)." Harvard Business School Supplement 514-092, January 2014. (Revised January 2014.) (This case is a follow up to GlaxoSmithKline (A), 514049 and GlaxoSmithKline (B), 514050.)
- November 2016
- Case
QuintilesIMS: Biosimilar Marketing in England
By: John A. Quelch and Emily C. Boudreau
QuintilesIMS was a leading healthcare consulting firm best known for its data and information offerings as well as its market research and management consulting services for life science companies. By 2015, the company was expanding beyond the biopharmaceutical... View Details
Keywords: Health; Pharmaceutical Industry; Biotech; Marketing; Health Care and Treatment; Biotechnology Industry; England
Quelch, John A., and Emily C. Boudreau. "QuintilesIMS: Biosimilar Marketing in England." Harvard Business School Case 517-054, November 2016.
- January 2017 (Revised October 2018)
- Case
Novartis: A Transformative Deal
By: David Collis and Ashley Hartman
When Joe Jimenez became CEO of Swiss-based Novartis in 2010, replacing longtime CEO Dan Vasella, he assumed control of one of the top pharmaceutical companies in the world. Vasella, an avowed advocate of diversification, had expanded the scope of the company and... View Details
Keywords: Novartis; GlaxoSmithKline; Asset Swap; Acquisitions; Divestiture; Strategy Alignment; Pharmaceuticals; Strategy; Business Strategy; Corporate Strategy; Diversification; Consolidation; Mergers and Acquisitions; Pharmaceutical Industry
Collis, David, and Ashley Hartman. "Novartis: A Transformative Deal." Harvard Business School Case 717-453, January 2017. (Revised October 2018.)
- Fall 2019
- Article
Du « défi américain » à l’expansion européenne: Les relations économiques transatlantiques des années cinquante aux années soixante-dix
By: Grace A. Ballor
Economic histories of post-war transatlantic relations have focused on two predominant narratives: US aid for European reconstruction through the Marshall Plan, and the threat of American business investment in Europe. But little research has linked these two elements.... View Details
Keywords: Multinational Corporations; Economic History; International Relations; Business History; Foreign Direct Investment; Multinational Firms and Management
Ballor, Grace A. "Du « défi américain » à l’expansion européenne: Les relations économiques transatlantiques des années cinquante aux années soixante-dix." Relations internationales 180, no. 4 (Fall 2019): 43–57.
- 2022
- Article
‘American Management’ vs ‘Swiss Labour Peace’. The Closure of the Swiss Firestone Factory in 1978
By: Sabine Pitteloud
This article focusses on the closure of the Firestone’s Swiss subsidiary in 1978. It contributes to the existing literature dealing with the ‘nationality’ of multinational companies and the impact of U.S. management style on local capitalist systems. Drawing on a... View Details
Keywords: Americanization; Capitalism; Corporate Nationality; Industrial Relations; Multinational; Narratives; Multinational Firms and Management; Nationality; Economic Systems; Labor and Management Relations; Switzerland
Pitteloud, Sabine. "‘American Management’ vs ‘Swiss Labour Peace’. The Closure of the Swiss Firestone Factory in 1978." Special Issue on International Business, Multi-Nationals, and the Nationality of the Company. Business History 64, no. 9 (2022): 1648–1665.
- September–October 2017
- Article
GE's Global Growth Experiment: The Company Pushed Cross-Business Collaboration
By: Ranjay Gulati
Like many other companies, GE under Immelt had to figure out how to balance serving local needs with the economies of worldwide scale. Harvard Business School’s Ranjay Gulati looks at how it tackled the challenge. He identifies several important takeaways for other... View Details
Gulati, Ranjay. "GE's Global Growth Experiment: The Company Pushed Cross-Business Collaboration." Harvard Business Review 95, no. 5 (September–October 2017): 52–53.
- January–February 2015
- Article
Heroic Villains: Are Foreign Investors Problems or Solutions in the Ebola Crisis?
By: Debora L. Spar
For months, the news out of West Africa has been unrelentingly grim. As of early December, the devastating Ebola epidemic had infected a reported 17,942 people and killed 6,388, according to the World Health Organization (WHO); the actual toll, which would also account... View Details
Keywords: Ebola; Multinational Corporation; Epidemics; Foreign Investment; Extractive Industries; Multinational Firms and Management; Health Pandemics; Developing Countries and Economies; Government and Politics; Africa
Spar, Debora L. "Heroic Villains: Are Foreign Investors Problems or Solutions in the Ebola Crisis?" Foreign Policy 210 (January–February 2015).
- 26 Apr 2023
- Cold Call Podcast
How Martine Rothblatt Started a Company to Save Her Daughter
- October 2022 (Revised September 2024)
- Case
mPharma: Scaling Access to Affordable Primary Care in Africa
By: Regina E. Herzlinger and Ben Creo
mPharma hopes to scale up to create the largest pan-African healthcare company ever to provide much-needed primary care in retail pharmacies; a reliable, fairly priced supply of drugs; and micro-insurance for drugs. They must prioritize launching a telemedicine... View Details
Keywords: Africa; Pharmaceutical Companies; Pharmacy Benefit Manager; Health Care; Health Care And Treatment; Health Care Costs; Health Care Delivery; Health Care Entrepreneurship; Telehealth; Health Equity; Corporate Strategy; Social Entrepreneurship; Equity; Growth and Development Strategy; Expansion; Product Launch; Customer Value and Value Chain; Social Enterprise; Multinational Firms and Management; Pharmaceutical Industry; Pharmaceutical Industry; Africa
Herzlinger, Regina E., and Ben Creo. "mPharma: Scaling Access to Affordable Primary Care in Africa." Harvard Business School Case 323-033, October 2022. (Revised September 2024.)
- May 2005 (Revised October 2022)
- Case
The Octopus and the Generals: The United Fruit Company in Guatemala
By: Geoffrey Jones and Marcelo Bucheli
Examines the overthrow of President Jacobo Arbenz of Guatemala in 1954 in a U.S.-backed coup in support of the United Fruit Co. Over the previous half century, United Fruit had built a large vertically integrated tropical fruit business that owned large banana... View Details
Keywords: Developing Countries and Economies; Multinational Firms and Management; Policy; International Relations; Business History; Business and Government Relations; Central America; Guatemala; United States
Jones, Geoffrey, and Marcelo Bucheli. "The Octopus and the Generals: The United Fruit Company in Guatemala." Harvard Business School Case 805-146, May 2005. (Revised October 2022.)
- 04 Feb 2019
- Blog Post
Presenting…an Alternative to Company Presentations: Evercore Grabs Attention with Interactive Events
case study. When they added two more ingredients to the recipe – a focus on a familiar industry, amplified by media exposure the audience would recognize – they arrived at the heart of their presentation; a “live” case study about Evercore’s role in a recent M&A:... View Details
- September 2019 (Revised July 2021)
- Case
Gap, Inc., 2019
By: John R. Wells and Benjamin Weinstock
In 2000, The Gap, Inc. (Gap) was the world’s largest player in specialty fashion retailing, and companies such as Inditex of Spain, H&M of Sweden, and Fast Retailing of Japan were less than a quarter of Gap’s size. But after two decades of growth, Gap’s progress... View Details
Keywords: Strategic Change; Fashion; Multinational; Brands; Fast Fashion; Competition; Multinational Firms and Management; Performance Improvement; Management Teams; Brands and Branding; Change Management; Strategy; Retail Industry; Fashion Industry; Apparel and Accessories Industry; Sweden; Spain; United States
Wells, John R., and Benjamin Weinstock. "Gap, Inc., 2019." Harvard Business School Case 720-377, September 2019. (Revised July 2021.)
- July 2011 (Revised June 2013)
- Case
Foxconn Technology Group (A)
By: Robert G. Eccles, George Serafeim and Beiting Cheng
In 2010, Foxconn Technology Group, the largest and fastest growing multinational company in the Electronic Manufacturing Services (EMS) industry, came under public scrutiny after a string of employee suicides reached the international press. Although the company was... View Details
Keywords: Multinational; Labor Market; Electronic Manufacturing Services; Health & Wellness; Robots; Automation; Social Responsibility; Employee Relationship Management; Leadership; Stocks; Social Issues; Corporate Social Responsibility and Impact; Capital Markets; Supply Chain Management; Safety; Environmental Accounting; Human Capital; Human Resources; Electronics Industry; Manufacturing Industry; China
Eccles, Robert G., George Serafeim, and Beiting Cheng. "Foxconn Technology Group (A)." Harvard Business School Case 112-002, July 2011. (Revised June 2013.)
- 2019
- Article
The Social Desirability of Offshoring: A Swiss Consensus (1945–1975)
By: Sabine Pitteloud
This article focuses on the evolution of the rhetoric and practice of corporate offshoring in Switzerland from the post-war economic boom to the industrial crisis in the mid-seventies. The virtue of a historical perspective on the issue of offshoring is to show how... View Details
Keywords: Multinationals; Offshoring And Outsourcing; Relocation; Labor Relations; Multinational Firms and Management; Labor and Management Relations; Job Cuts and Outsourcing; Switzerland
Pitteloud, Sabine. "The Social Desirability of Offshoring: A Swiss Consensus (1945–1975)." Zeitschrift für Unternehmensgeschichte 64, no. 2 (2019).
- October 2014 (Revised May 2017)
- Teaching Note
Pfizer and AstraZeneca: Marketing an Acquisition (A) & (B)
By: John A. Quelch
- February 2015 (Revised November 2015)
- Case
Building an Integrated Biopharma Company: Crucell (A)
By: Richard G. Hamermesh, Marianne Van Der Steen and Susan S. Harmeling
By 2009, Crucell had become the largest biopharma company in the Netherlands and a symbol of national pride. The case traces the evolution of the company from a University spin-off into a fully-integrated company. Crucell's success, particularly in the vaccine space,... View Details
Keywords: Biotechnology; Biopharmacy Company; Licensing; Licensing Agreements In Biopharmacy; Human Cell-line Technology; Vaccine; Healthcare Innovation; Global Health; Partners and Partnerships; Entrepreneurship; Growth and Development Strategy; Pharmaceutical Industry; Pharmaceutical Industry; Netherlands
Hamermesh, Richard G., Marianne Van Der Steen, and Susan S. Harmeling. "Building an Integrated Biopharma Company: Crucell (A)." Harvard Business School Case 815-085, February 2015. (Revised November 2015.)
- 01 Dec 2013
- News
Your Own Medicine
help build new muscle—had been one of several potential treatments the Secklers chased to no avail, often stuck following promising science to dead ends. That changed three years ago, when former pharmaceutical executive Gene Williams... View Details
- 16 May 2018
- Research & Ideas
How Companies Managed Risk (and Even Benefitted) in World War Internment Camps
companies from Germany dealt with the incarceration of thousands of their German national employees in India during World War I and World War II in her recent working paper, Countering Political Risk in Colonial India: German View Details
- 28 Feb 2020
- News
Filling the White Space
companies involved in research into psychedelic compounds for medical use. (Compass has been granted a US patent that covers a method of obtaining psilocybin to treat drug-resistant depression; the treatment is in a phase IIb clinical... View Details
- October 1993 (Revised February 1995)
- Case
Dendrite International
By: Frank V. Cespedes and Marie Bell
Dendrite International is a $23 million (1992 revenues) supplier of sales automation software to pharmaceuticals companies in Europe, Japan, and the United States. The firm's strategy has depended on being a full-service supplier to multinational firms. Impending... View Details
Keywords: Accounting Audits; Cost vs Benefits; Forecasting and Prediction; Marketing Strategy; Risk and Uncertainty; Sales; Competitive Advantage; Information Technology Industry; Japan; Europe; United States
Cespedes, Frank V., and Marie Bell. "Dendrite International." Harvard Business School Case 594-048, October 1993. (Revised February 1995.)